• PRELADENANT chembl:CHEMBL240624

    Alternate Names:

    PRELADENANT
    MK-3814
    SCH-420814

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antiparkinson agent
    (0 More Sources)

    Publications:

  • Interaction Score: 1.41

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name preladenant, SCH-420814
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 0.97

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Adenosine A2a receptor antagonist
    Direct Interaction yes

    PMIDs:
    None found